Skip to main content
Equibles

SMT · Sahajanand Medical Technologies Limited

Use SMT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SMT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
533.95 INR +29.30 (+5.81%) At close · Nov 13
Rebalance outlook locked
Market Cap
54.27B INR
Shares
101.65M
Volume · Nov 13 1.93M Avg daily vol (14 sessions) 2.7M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close533.95 INR Open505.00 INR Day492.05–544.00 INR Available close range455.00–534.70 INR Avg vol available · 14d2.7M Last earningsNov 5, 2026 DataOct 2026–Nov 2026

The closing range uses available history since Oct 27, 2026; less than a full year is stored.

Latest documents

2026
Nov 5
Earnings call
Record Results Drive EBITDA Margin Expansion

SMT reported quarter two FY 2027 revenue of around INR373 crores, up 24.7%, and EBITDA of INR65 crores, up 36.6%, lifting margin to 17.6%. Sironity was commercialized in India, while AVDC 1.5 received CE approval.

3 source passages
Quarter two FY 2027 was a record quarter for SMT, with the highest-ever revenue, EBITDA, and PAT. Revenue grew 24.7% to around INR373 crores. EBITDA grew faster, up 36.6% to INR65 crores, and the EBITDA margin rose from 16% to 17.6%. Sironity, our sirolimus drug-coated balloon, is now commercialized in India. On the delivery side, AVDC 1.5 also received the CE approval earlier in the year. Open the document at this passage
All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its available closing range
Range low 455.00 INR Now 533.95 INR · 99% Range high 534.70 INR

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:SMT +1.5% — — +17.4% —

Exchange listing

Market
XNSE
Ticker
SMT
ISIN
INE356Y01018
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.smtpl.com/
Investor relations
https://www.smtpl.com/investor

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Transcript
    Earnings Call